Androgen Deprivation Therapy

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Androgen Deprivation Therapy is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

29/100

Attrition Rate

38/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Terminated3 · 23%

Recruiting3 · 23%

Completed2 · 15%

Active, not recruiting2 · 15%

Withdrawn2 · 15%

Unknown status1 · 8%

Clinical Trials

Trial Activity

13 trials

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Recruiting·EEuropean Organisation for Research and Treatment of Cancer - EORTC·Phase 3·NCT05974774·1,600 enrolled

Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma

Recruiting·PPeking University First Hospital·Phase 2·NCT06348264·37 enrolled

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

Recruiting·TThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School·Phase 2·NCT06992232·144 enrolled

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Active, not recruiting·—·Phase 2·NCT06463457·33 enrolled

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

Active, not recruiting·HH. Lee Moffitt Cancer Center and Research Institute·Phase 1/2·NCT03543189·44 enrolled

Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy Staging

Completed·UUrology Clinics of North Texas·Phase 1·NCT07069465·10 enrolled

Micro RNAs to Predict Response to Androgen Deprivation Therapy

Completed·MMedical College of Wisconsin·N/A·NCT02366494·42 enrolled

Androgen Deprivation Therapy Study

Terminated·National Institute on Aging (NIA)·N/A·NCT00743327·1 enrolled

Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose

Terminated·NNorwegian School of Sport Sciences·N/A·NCT03440879·23 enrolled

Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT

Terminated·—·Phase 3·NCT03777982·12 enrolled

Study of Dasatinib, Androgen Deprivation Therapy and Radiation

Withdrawn·—·Phase 1·NCT01826838

Black Cohosh for Host Flashes Due to Androgen Deprivation Therapy

Withdrawn·MMidwestern Regional Medical Center·Phase 2·NCT02952742

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Unknown status·FFudan University·Phase 2·NCT02742675·200 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)